ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

Tolerance of Atovacuona/proguanil in off-label indication in children

Tolerancia de Atovacuona/proguanil en niños con indicación fuera de ficha técnica

Lorea Vicente Elcanoa,

Corresponding author

lorea.vicente@salud.madrid.org

Corresponding author.

, Cecilia Muruzábal Pinoa, Cristina Calvoa,b,c,d, Milagros García López Hortelanoa,c,e

a Pediatric and Infectious Diseases Department, La Paz University Hospital, Madrid, Spain

b La Paz Institute for Health Research (IdiPAZ), Madrid, Spain

c Biomedical Research Network Centre for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain

d Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain

e Pediatric Tropical Diseases Unit, International Adoption and Consultation of Traveling Children, La Paz University Hospital, Madrid, Spain

Read

447

Times
was read the article

Total PDF

372

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2024.06.012

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	89	20	109
2024 November	53	9	62
2024 October	48	7	55
2024 September	63	14	77
2024 August	119	25	144

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter